Frequency of Hymenoptera-stings in Patients Under Allergen-Specific Immunotherapy (SIT) (ZU-HVA-001)

This study has been completed.
Sponsor:
Information provided by:
University of Zurich
ClinicalTrials.gov Identifier:
NCT00742794
First received: August 27, 2008
Last updated: August 18, 2010
Last verified: September 2008
  Purpose

In Switzerland, 3.5% of the population are suffering from hymenoptera venom allergy. The only causal treatment of hymenoptera alelrty is venom specific immunotherapy. There are however several reasons, which question the relatively broad application of this expensive treatment. That's why we aim at investigating the actual risk for hymenoptera stings in patients undergoing allergen specific immunotherapy against hymenoptera sting allergy


Condition Intervention Phase
Hymenoptera Sting Allergy
Other: Observation
Phase 4

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Frequency of Hymenoptera-stings in Patients Under and After Allergen-specific Immunotherapy: a Retrospective Data-analysis Considering Socio-economic Aspects

Resource links provided by NLM:


Further study details as provided by University of Zurich:

Estimated Enrollment: 200
Study Start Date: August 2008
Study Completion Date: August 2010
Groups/Cohorts Assigned Interventions
1
Hymenoptera sting allergic patients under immunotherapy
Other: Observation
Observation of sting frequency

  Eligibility

Ages Eligible for Study:   5 Years to 90 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

Hymenoptera sting allergic patients under allergen specific immunotherapy

Criteria

Inclusion criteria:

  • Bee and/or Wasp allergic patients treated by SIT

Exclusion criteria:

  • None
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00742794

Locations
Switzerland
Zurich, Switzerland
Sponsors and Collaborators
University of Zurich
Investigators
Study Director: 01 Studienregister MasterAdmins UniversitaetsSpital Zuerich
  More Information

No publications provided

Responsible Party: G.Senti, University of Zurich
ClinicalTrials.gov Identifier: NCT00742794     History of Changes
Other Study ID Numbers: ZU-HVA-001
Study First Received: August 27, 2008
Last Updated: August 18, 2010
Health Authority: Switzerland: Swissmedic

Additional relevant MeSH terms:
Bites and Stings
Poisoning
Substance-Related Disorders
Wounds and Injuries

ClinicalTrials.gov processed this record on July 22, 2014